About VPHi
Formed in 2011, the Virtual Physiological Human Institute for Integrative Biomedical Research, in short VPH Institute, is an international not for profit organisation, whose mission is to ensure that the Virtual Physiological Human (VPH), is fully realised, universally adopted, and effectively used both in research and clinic. It is also identified with the word “in silico medicine”.
VPHi Zenodo community
As a partner is various European and international projects and initiatives, the VPHi has been producing several deliverables including reports, survey dataset, white papers, standard procedures, etc.. The Zenodo VPHi community has been created in order to allow for open access to this public resources with unique identifiers by the VPHi community as well as to connect and synergize outputs from various projects and foster exchanges within the community.
About VPHi
Formed in 2011, the Virtual Physiological Human Institute for Integrative Biomedical Research, in short VPH Institute, is an international not for profit organisation, whose mission is to ensure that the Virtual Physiological Human (VPH), is fully realised, universally adopted, and effectively used both in research and clinic.
The VPH, also identified with the word “in silico medicine”, is the field that uses individualised physiology-based computer models and simulations or data driven models to assist and improve all aspects of healthcare, ranging from prevention, over diagnosis and prognostic assessment to treatment, including the design and development of biomedical products. The VPHi membership and participation are open to any scientists, clinicians and healthcare professionals focused on the development and uptake of computer modeling & simulation in healthcare and currently we represent many of the largest in silico medicine research groups worldwide.
The VPHi acts as a catalyst to bring together a variety of different stakeholders (policy makers, science funding bodies, regulatory agencies, clinical organisations and industry) in order to maximise the benefit of in silico medicine approaches for the healthcare industry and for the public good.
More information available on our website: www.vph-institute.org